v3.26.1
Share based Compensation
3 Months Ended
Mar. 31, 2026
Share based Compensation  
Share-based Compensation

12. Share-based Compensation

 

Share-based compensation (including RSAs) represents both stock option-based expense and stock grant expense.  The following table sets forth the composition of stock compensation expense included in general and administrative expense for the periods then ended:

 

 

 

THREE MONTHS ENDED

 

 

 

MARCH 31,

 

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

Restricted share-based compensation expense

 

$153,539

 

 

$170,781

 

Non-qualified option share-based compensation expense

 

 

95,278

 

 

 

28,078

 

 

 

 

 

 

 

 

 

 

Total share-based compensation before taxes

 

$248,817

 

 

$198,859

 

 

Restricted Stock

 

The Company records the fair value of all restricted stock shares based on the grant date fair value and amortizes stock compensation on a straight-line basis over the vesting period. Restricted stock award shares are issued when granted and included in the total number of common shares issued and outstanding. There were no restricted stock awards granted during the three months ended March 31, 2026 and 2025.

 

Stock Options 

 

The Company estimates the fair value of nonqualified stock awards using a Black-Scholes Option Pricing model (“Black-Scholes model”). The fair value of each stock award is estimated on the date of grant using the Black-Scholes model, which requires an assumption of dividend yield, risk free interest rates, volatility, and expected option life. The risk-free interest rates are based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. Expected volatilities are based on the historical volatility of our common stock over the expected option term. The expected term of options granted is calculated using the simplified method. The Company recognizes forfeitures as they occur. There were 100,000 stock option awards granted during the three months ended March 31, 2026. There were no stock option awards granted during the three months ended March 31, 2025.

 

For the three months ended March 31, 2026, the weighted-average grant date fair value per option was $0.68 - $2.51. Option pricing model assumptions for NQSO awards granted were valued using the following assumptions for the period then ended as set forth below:

 

 

 

THREE MONTHS ENDED

 

 

 

MARCH 31,

 

 

 

2026

 

 

2025

 

 

 

 

 

 

 

 

Expected dividend yield

 

 

0%

 

 

--

 

Expected volatility

 

 

66.8%

 

 

--

 

Risk-free interest rate

 

 

3.6%

 

 

--

 

Term

 

1.8 years

 

 

 

--

 

 

 

At March 31, 2026, the Company had approximately $0.4 million of total unrecognized share-based compensation expense related to share-based compensation that will be recognized over the weighted average remaining period of 1.1 years.